Recurrent Fallopian Tube Endometrioid Adenocarcinoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00158 | Folic acid | 1 / 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 / 2 | Recruiting | 1 |
| DB00112 | Bevacizumab | 2 | Recruiting | 1 |
| DB04849 | Cediranib | 2 | Active Not Recruiting | 1 |
| DB12483 | Copanlisib | 2 | Withdrawn | 1 |
| DB00997 | Doxorubicin | 2 | Active Not Recruiting | 1 |
| DB00997 | Doxorubicin | 2 | Withdrawn | 1 |
| DB11714 | Durvalumab | 2 | Active Not Recruiting | 1 |
| DB09074 | Olaparib | 2 | Active Not Recruiting | 2 |
| DB09074 | Olaparib | 2 | Withdrawn | 1 |
| DB01229 | Paclitaxel | 2 | Active Not Recruiting | 1 |
| DB01229 | Paclitaxel | 2 | Withdrawn | 1 |
| DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
| DB00759 | Tetracycline | 2 | Active Not Recruiting | 1 |
| DB00759 | Tetracycline | 2 | Withdrawn | 1 |
| DB01030 | Topotecan | 2 | Active Not Recruiting | 1 |
| DB01030 | Topotecan | 2 | Withdrawn | 1 |
| DB11771 | Tremelimumab | 2 | Active Not Recruiting | 1 |
| DB11595 | Atezolizumab | 2 / 3 | Active Not Recruiting | 1 |
| DB00112 | Bevacizumab | 2 / 3 | Active Not Recruiting | 1 |
| DB00997 | Doxorubicin | 2 / 3 | Active Not Recruiting | 1 |
| DB00759 | Tetracycline | 2 / 3 | Active Not Recruiting | 1 |